Duke Robotics (NASDAQ:DUKR) versus Mainz Biomed (NASDAQ:MYNZ) Head-To-Head Contrast

Mainz Biomed (NASDAQ:MYNZ) and Duke Robotics (NASDAQ:DUKR) are both small-cap industrials companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, dividends, profitability, risk and valuation.

Volatility & Risk

Mainz Biomed has a beta of 0.31, suggesting that its stock price is 69% less volatile than the S&P 500. Comparatively, Duke Robotics has a beta of 2.23, suggesting that its stock price is 123% more volatile than the S&P 500.

Profitability

This table compares Mainz Biomed and Duke Robotics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mainz Biomed	N/A	N/A	N/A
Duke Robotics	N/A	-146.36%	-86.13%

Valuation & Earnings

This table compares Mainz Biomed and Duke Robotics”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mainz Biomed	$659,935.00	13.18	-$21.65 million	($65.60)	-0.01
Duke Robotics	$380,000.00	38.36	-$1.24 million	($0.67)	-6.34

Duke Robotics has lower revenue, but higher earnings than Mainz Biomed. Duke Robotics is trading at a lower price-to-earnings ratio than Mainz Biomed, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent ratings and price targets for Mainz Biomed and Duke Robotics, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mainz Biomed	1	1	0	0	1.50
Duke Robotics	1	0	1	0	2.00

Duke Robotics has a consensus target price of $12.00, indicating a potential upside of 182.35%. Given Duke Robotics’ stronger consensus rating and higher possible upside, analysts clearly believe Duke Robotics is more favorable than Mainz Biomed.

Summary

Duke Robotics beats Mainz Biomed on 7 of the 11 factors compared between the two stocks.

About Mainz Biomed

Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. The company was founded in 2008 and is based in Mainz, Germany.

About Duke Robotics

Duke Robotics Corp (Nasdaq: DUKR) is a Fort Lauderdale, Florida–based company that develops advanced stabilization and autonomous robotic drone systems for both civilian and defense markets. On the civilian side, its Insulator Cleaning Drone (IC Drone) is a drone-enabled system for cleaning and monitoring high-voltage electric utility insulators, and its AEROTRACE platform uses AI-powered aerial monitoring to help infrastructure operators assess assets and prioritize maintenance. In defense, the company holds the intellectual property behind the Bird of Prey, a fully stabilized remote weapon system designed for non-line-of-sight and stand-off engagements, which is marketed by Elbit Systems Land Ltd. under the brand name Bird of Prey (formerly known as TIKAD).